This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Provid Pharmaceuticals Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Sudhir Kondapaka: Innovator in Kinase Inhibitors
Introduction
Sudhir Kondapaka is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.
Latest Patents
Sudhir Kondapaka holds a patent for "Kinase inhibitors, compositions thereof, and methods of use therewith." This patent includes compounds with specific structures that are essential for the development of effective kinase inhibitors. His innovative approach has led to advancements in the treatment of diseases where kinase activity plays a crucial role.
Career Highlights
Throughout his career, Sudhir has worked with prominent organizations, including Provid Pharmaceuticals Inc. and the United States of America, as represented by the Secretary, Department of Health and Human Services. His experience in these institutions has allowed him to contribute to significant research and development projects.
Collaborations
Sudhir has collaborated with notable colleagues such as Charles Michael Cook and Christopher Self. These partnerships have enhanced his research efforts and have been instrumental in the advancement of his work in kinase inhibitors.
Conclusion
Sudhir Kondapaka's contributions to the field of kinase inhibitors highlight his innovative capabilities and dedication to advancing pharmaceutical science. His work continues to impact the industry positively, paving the way for future developments in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile